Ann: Becoming a substantial holder, page-40

  1. 14,903 Posts.
    lightbulb Created with Sketch. 1669
    • Overall Success Rates: Approximately 13.8% of all drug development programs lead to approval, higher than earlier estimates of 10.4% and 9.6% from prior studies1.

    • Phase-Specific Success:

      • Phase I to Phase II: 52% success rate.

      • Phase II to Phase III: 28.9% success rate.

      • Phase III to NDA/BLA submission: 57.8% success rate.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.